The stock of Medtronic Plc (MDT) has seen a -0.50% decrease in the past week, with a -2.84% drop in the past month, and a 1.56% flourish in the past quarter. The volatility ratio for the week is 0.96%, and the volatility levels for the past 30 days are at 1.37% for MDT. The simple moving average for the last 20 days is -1.25% for MDT stock, with a simple moving average of 1.43% for the last 200 days.
Is It Worth Investing in Medtronic Plc (NYSE: MDT) Right Now?
The price-to-earnings ratio for Medtronic Plc (NYSE: MDT) is above average at 26.40x, Company’s 36-month beta value is 0.77.Analysts have differing opinions on the stock, with 7 analysts rating it as a “buy,” 4 as “overweight,” 12 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for MDT is 1.33B, and currently, short sellers hold a 0.64% ratio of that floaft. The average trading volume of MDT on March 26, 2024 was 6.13M shares.
MDT) stock’s latest price update
The stock of Medtronic Plc (NYSE: MDT) has increased by 0.19 when compared to last closing price of 83.08. Despite this, the company has experienced a -0.50% fall in its stock price over the last five trading sessions. The Motley Fool reported 2024-03-23 that The AI-in-healthcare market is expanding in the double digits and could reach more than $148 billion by the end of the decade. Nvidia CEO Jensen Huang says AI may have the most impact in the healthcare industry.
Analysts’ Opinion of MDT
Many brokerage firms have already submitted their reports for MDT stocks, with Robert W. Baird repeating the rating for MDT by listing it as a “Neutral.” The predicted price for MDT in the upcoming period, according to Robert W. Baird is $90 based on the research report published on July 19, 2023 of the previous year 2023.
CL King, on the other hand, stated in their research note that they expect to see MDT reach a price target of $106. The rating they have provided for MDT stocks is “Buy” according to the report published on June 30th, 2023.
Morgan Stanley gave a rating of “Overweight” to MDT, setting the target price at $104 in the report published on May 30th of the previous year.
MDT Trading at -2.53% from the 50-Day Moving Average
After a stumble in the market that brought MDT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -9.54% of loss for the given period.
Volatility was left at 1.37%, however, over the last 30 days, the volatility rate increased by 0.96%, as shares sank -0.51% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -4.42% lower at present.
During the last 5 trading sessions, MDT fell by -0.50%, which changed the moving average for the period of 200-days by +0.42% in comparison to the 20-day moving average, which settled at $84.27. In addition, Medtronic Plc saw 1.04% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at MDT starting from Salmon Sean, who sale 30,695 shares at the price of $85.13 back on Feb 21 ’24. After this action, Salmon Sean now owns 48,289 shares of Medtronic Plc, valued at $2,613,055 using the latest closing price.
Wall Brett A., the EVP & Pres Neuroscience of Medtronic Plc, sale 4,997 shares at $82.17 during a trade that took place back on Dec 19 ’23, which means that Wall Brett A. is holding 28,910 shares at $410,603 based on the most recent closing price.
Stock Fundamentals for MDT
Current profitability levels for the company are sitting at:
- 0.18 for the present operating margin
- 0.65 for the gross margin
The net margin for Medtronic Plc stands at 0.13. The total capital return value is set at 0.07. Equity return is now at value 8.14, with 4.54 for asset returns.
Based on Medtronic Plc (MDT), the company’s capital structure generated 0.33 points at debt to capital in total, while cash flow to debt ratio is standing at 0.26. The debt to equity ratio resting at 0.49. The interest coverage ratio of the stock is 8.05.
Currently, EBITDA for the company is 9.04 billion with net debt to EBITDA at 2.76. When we switch over and look at the enterprise to sales, we see a ratio of 4.15. The receivables turnover for the company is 5.42for trailing twelve months and the total asset turnover is 0.36. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.30.
Conclusion
In a nutshell, Medtronic Plc (MDT) has experienced a mixed performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
